Filters
reset all| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Mayo Clinic Laboratories Mayo Clinic United States | 5 | 5 |
|
SCA Panel (SCA1, 2, 3, 6, 7) test Neurogenetics Department Cyprus Institute of Neurology and Genetics Cyprus | 5 | 5 |
|
Ataxin 3 (ATXN3) gene CAG triplet repeat test Neurogenetics Department Cyprus Institute of Neurology and Genetics Cyprus | 1 | 1 |
|
ATXN3 - Repeat expansion analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
Centogene AG - the Rare Disease Company Germany | 13 | 13 |
|
Machado-Joseph Disease (MJD)/Spinocerebellar Ataxia Type 3 (SCA3) via the ATXN3 CAG Repeat Expansion PreventionGenetics United States | 1 | 1 |
|
Spinocerebellar ataxia type 3 presymptomatic testing Genetics Service Unit National Institute of Biomedical Genomics India | 1 | 1 |
|
Genetics Service Unit National Institute of Biomedical Genomics India | 1 | 1 |
|
Molecular Diagnostic Laboratory Diagnostic Services, Shared Health Manitoba Canada | 1 | 1 |
|
Spinocerebellar Ataxia type 3, Machado Joseph disease (SCA3, CAG expansion on ATXN3 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Spinocerebellar Ataxia (SCA) Type 3 Duzen Laboratories Duzen BBAGUAS Turkey | 1 | 1 |
|
Spinocerebellar Ataxia Type 3 Repeat Analysis GeneDx United States | 1 | 1 |
|
Spinocerebellar Ataxia Repeat Expansion Analysis GeneDx United States | 6 | 6 |
|
Comprehensive Ataxia Repeat Expansion Panel (SCA 1, 2, 3, 6, 7, 8, 10, 12, 17, 36, DRPLA & FRDA) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 12 | 12 |
|
ATXN3 (Spinocerebellar Ataxia Type 3) Repeat Expansion Fulgent Genetics United States | 1 | 1 |
|
Ataxia Repeat Expansion Analysis Fulgent Genetics United States | 19 | 15 |
|
Molecular Genetics Laboratory North York General Hospital Canada | 1 | 1 |
|
MNG Laboratories (Medical Neurogenetics, LLC.) United States | 11 | 11 |
|
SPINOCEREBELLAR ATAXIA (AUTOSOMAL DOMINANT) (SCAs) Laboratorio de Genetica Clinica SL Spain | 18 | 19 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.